NCT02071147

Brief Summary

Purpose: To examine the safety of omitting the routine postoperative eye clinic review following phacoemulsification cataract surgery. Background: Approximately 300000 cataract extractions are performed annually in the NHS in England, requiring a similar number of post-operative visits, the majority of which result in no change in management. A conservative estimate of 70% of visits being unnecessary suggests a potential saving to the NHS of approximately £10M annually. What's involved: The study involves some questionnaires during the duration of the study. These include questionnaires relating to the quality of life of the patient (conducted before the operation, and at the 3 month research clinic) and a patient satisfaction questionnaire. There is also a research clinic 3 months following the operation. What are the risks/benefits: There are no real personal benefits to patients on the trial. The trial aims to provide very important information regarding the safety of discharging patients immediately after surgery. However the trial could potentially save many thousands of unnecessary hospital visits each year.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

February 21, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 25, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 10, 2016

Completed
7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2023

Completed
Last Updated

November 29, 2024

Status Verified

November 1, 2024

Enrollment Period

2.5 years

First QC Date

February 21, 2014

Last Update Submit

November 27, 2024

Conditions

Keywords

Follow-upNo follow-upremovalRandomised Controlled Trial6 Weeks

Outcome Measures

Primary Outcomes (2)

  • Corrected distance visual acuity (VA)

    3 Months

  • Vision-related quality of life impairment measures are the VCM1 and Catquest questionnaires

    3 Months

Secondary Outcomes (2)

  • Post operative complication rate between the two groups

    3 Months

  • Post operative patient satisfaction between the two groups

    3 months

Study Arms (2)

Standard clinical intervention

OTHER

Patients reviewed at 6 weeks (+/- 1 week) as is our normal practice and recalled for a further evaluation if deemed appropriate. Patients will be instructed to visit their optometrist once their eye has fully recovered from the operation for provision of glasses.

Other: Quality of Life questionnaireOther: Patient satisfaction Questionnaire

No Clinical Follow up

OTHER

No routine follow-up appointment is made. Patients will be instructed to visit their optometrist between 6-8 weeks post-operative for review of the patient's glasses.

Other: No Clinical Follow upOther: Quality of Life questionnaireOther: Patient satisfaction Questionnaire

Interventions

No Clinical Follow up
Also known as: VQOL
No Clinical Follow upStandard clinical intervention

Conducted at Research clinic.

No Clinical Follow upStandard clinical intervention

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults Aged \>= 40 years
  • Scheduled for day-case cataract surgery
  • Able to give informed consent

You may not qualify if:

  • Unable to provide written informed consent
  • Unable to visit their optometrist post operatively
  • Patients with ocular comorbidity that may be affected by cataract surgery or who require monitoring within three months of their operation (including significant diabetic retinopathy, wet age-related macular degeneration (AMD) on treatment, severe/end-stage glaucoma, previous retinal detachment or vitrectomy)
  • Patients undergoing another simultaneous ophthalmic procedure
  • Patients who suffer from an intra-operative complication requiring early postoperative evaluation (identified at surgery).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Torbay District General Hospital

Torquay, Devon, TQ2 7AA, United Kingdom

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Andrew Frost, MBchB, MRCP, FRCOphth, PHD

    Torbay and South Devon NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 21, 2014

First Posted

February 25, 2014

Study Start

February 1, 2014

Primary Completion

August 10, 2016

Study Completion

August 10, 2023

Last Updated

November 29, 2024

Record last verified: 2024-11

Locations